Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Tumor necrosis factor-alpha promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensitivity reaction in the skin of borderline tuberculoid leprosy patients.

Moraes MO, Duppre NC, Suffys PN, Santos AR, Almeida AS, Nery JA, Sampaio EP, Sarno EN.

Immunogenetics. 2001 Feb;53(1):45-7. No abstract available.

PMID:
11261930
2.

Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients.

Santos AR, Almeida AS, Suffys PN, Moraes MO, Filho VF, Mattos HJ, Nery JA, Cabello PH, Sampaio EP, Sarno EN.

Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):325-7. No abstract available.

PMID:
11221098
3.

Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy.

Roy S, McGuire W, Mascie-Taylor CG, Saha B, Hazra SK, Hill AV, Kwiatkowski D.

J Infect Dis. 1997 Aug;176(2):530-2.

PMID:
9237725
4.

Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy.

Santos AR, Suffys PN, Vanderborght PR, Moraes MO, Vieira LM, Cabello PH, Bakker AM, Matos HJ, Huizinga TW, Ottenhoff TH, Sampaio EP, Sarno EN.

J Infect Dis. 2002 Dec 1;186(11):1687-91. Epub 2002 Nov 11.

PMID:
12447749
6.

Interleukin-1 receptor antagonist and tumour necrosis factor-alpha gene polymorphisms in Turkish patients with allergic contact dermatitis.

Ertam I, Itirli G, Onay H, Alper S, Ozkinay F.

Contact Dermatitis. 2009 Aug;61(2):86-90. doi: 10.1111/j.1600-0536.2009.01593.x.

PMID:
19706048
7.

Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.

Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR.

Cancer Causes Control. 2004 Sep;15(7):657-63.

PMID:
15280623
8.

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW; European Study Group of Primary Sclerosing Cholangitis.

Gut. 2001 Aug;49(2):288-94.

9.

Tumor necrosis factor-alpha gene promoter polymorphism in coal workers' pneumoconiosis.

Kim KA, Cho YY, Cho JS, Yang KH, Lee WK, Lee KH, Kim YS, Lim Y.

Mol Cell Biochem. 2002 May-Jun;234-235(1-2):205-9.

PMID:
12162435
10.

A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.

Dawlah ZM, Cabrera A, Ahern K, Levis WR.

Int J Lepr Other Mycobact Dis. 2002 Mar;70(1):38-43. No abstract available.

PMID:
12120041
11.

Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.

Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN.

Br J Dermatol. 2007 Aug;157(2):273-83. Epub 2007 Jun 6.

PMID:
17553031
12.

Leprosy type 1 reaction spares the scars in a patch of borderline tuberculoid leprosy.

Walker SL, Lewis TG, Mahat K, Hawksworth RA.

Br J Dermatol. 2008 Mar;158(3):648-9. doi: 10.1111/j.1365-2133.2007.08395.x. Epub 2008 Jan 17. No abstract available.

PMID:
18205873
13.

Detection of S-100 antigen and anti ceramide antibody in sera of leprosy patients with and without reaction.

Narayan R, Maheshwari PK, Desikan KV, Harinath BC.

Indian J Lepr. 1997 Oct-Dec;69(4):347-52.

PMID:
9474510
14.
15.

Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil.

Franceschi DS, Mazini PS, Rudnick CC, Sell AM, Tsuneto LT, Ribas ML, Peixoto PR, Visentainer JE.

Int J Infect Dis. 2009 Jul;13(4):493-8. doi: 10.1016/j.ijid.2008.08.019. Epub 2008 Dec 5.

16.

Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction.

Harcos P, Laki J, Kiszel P, Széplaki Z, Szolnoki Z, Kovács M, Melegh B, Széplaki G, Füst G, Blaskó B.

Cytokine. 2006 Jan 21;33(2):100-5. Epub 2006 Feb 10.

PMID:
16473522
17.

Adrenocortical hormones and interleukin patterns in leprosy.

Leal AM, Magalhães PK, Souza CS, Foss NT.

Parasite Immunol. 2003 Aug-Sep;25(8-9):457-61.

18.

In vitro and skin lesion cytokine profile in Brazilian patients with borderline tuberculoid and borderline lepromatous leprosy.

Venturini J, Soares CT, Belone Ade F, Barreto JA, Ura S, Lauris JR, Vilani-Moreno FR.

Lepr Rev. 2011 Mar;82(1):25-35.

PMID:
21644469
19.

An investigation of mast cells in two basic leprosy groups.

Aroni K, Kontochristopoulos G, Liossi A, Panteleos D.

Int J Lepr Other Mycobact Dis. 1993 Dec;61(4):634-5. No abstract available.

PMID:
8151199
20.

Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension.

Chen YP, Pfab T, Slowinski T, Richter CM, Godes M, Hocher B.

Chin Med J (Engl). 2006 May 5;119(9):719-24.

PMID:
16701011

Supplemental Content

Support Center